MagneThermoPro : Magnetic Resonance Thermography of Human Prostate
ThermoPro
1 other identifier
interventional
70
1 country
1
Brief Summary
The objective of this project is to offer a very innovative solution for measuring temperature variations in MRI on the prostate. Multiparametric prostate MRI can detect target lesions, on which targeted biopsies are then performed. The use of a temperature mapping on the prostate in MRI would make it possible to evaluate a focal treatment of the prostate by laser under MRI guidance
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2021
CompletedFirst Posted
Study publicly available on registry
March 30, 2021
CompletedStudy Start
First participant enrolled
July 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 8, 2023
CompletedJanuary 2, 2024
December 1, 2023
11 months
March 25, 2021
December 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
signal noise ratio
the evaluation of the signal on the thermometry sequence
End of MRI exam (hour 1)
Secondary Outcomes (2)
temperature variance
End of MRI exam (hour 1)
spatial distortion measurement
End of MRI exam (hour 1)
Study Arms (1)
Thermometry MRI
EXPERIMENTALMRI sequence of 5 to 10 minutes to measure the variation of temprerature in the prostate
Interventions
MRI sequence of 5 to 10 minutes to measure the variation of temprerature in the prostate
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years old
- Patient with indication of injected multi-parameter MRI for the diagnosis of prostate cancer.
- Signed informed consent.
- Person affiliated or beneficiary of health insurance
You may not qualify if:
- MRI contraindications (Pace Maker, metallic foreign body, metallic heart valve).
- Contraindication to gadolinium salt,
- Patient under legal protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Bordeaux
Bordeaux, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 25, 2021
First Posted
March 30, 2021
Study Start
July 8, 2022
Primary Completion
June 8, 2023
Study Completion
June 8, 2023
Last Updated
January 2, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share